PF-Atlas › Clinical Trials › NCT00515229

Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo

amitriptyline · Phase 2

Registry ID

NCT00515229

Phase

Phase 2

Status

Completed

Drug / intervention

amitriptyline

Sponsor

University Hospital Tuebingen

Start

2006-10

About this trial

amitriptyline is evaluated in NCT00515229, a Phase 2 idiopathic pulmonary fibrosis study sponsored by University Hospital Tuebingen. Current status: Completed.

View NCT00515229 on ClinicalTrials.gov →

Explore related

All amitriptyline trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00515229 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.